METHODS OF DETECTING LOSS OF HETEROZYGOSITY AND DAMAGING MUTATIONS IN IMMUNERELATED GENES IN LIQUID BIOPSIES
US Application 63/572,760
Filed on 2024-04-01
Filed on 2024-04-01
T CELL RECEPTORS TARGETING E545K OR N345K MUTATION IN PIK3CA
US Application 63/565,764
Filed on 2024-03-15
Filed on 2024-03-15
POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4
US Application 63/575,037
Filed on 2024-04-05
Filed on 2024-04-05
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 AND/OR CD276 AND THEIR USE FOR TREATING SOLID TUMORS
US Application 63/644,728
Filed on 2024-05-09
Filed on 2024-05-09
Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma
US Application 63/634,330
Filed on 2024-04-15
Filed on 2024-04-15
MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (RO4 antibody)
US Application 63/550,703
Filed on 2024-02-07
Filed on 2024-02-07
QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY
US Application 63/651,184
Filed on 2024-05-23
Filed on 2024-05-23
BIVALENT COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME
US Application 63/610,555
Filed on 2023-12-15
Filed on 2023-12-15
TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB
US Application 63/608,127
Filed on 2023-12-08
Filed on 2023-12-08
PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY
US Application 63/626,277
Filed on 2024-01-29
Filed on 2024-01-29